West Pharmaceutical Services Inc (NYSE:WST)
| 151.49 Delayed Data As of Apr 03 |  -4.19 / -2.69%Today’s Change | 109.88 Today|||52-Week Range 176.66 | +0.77% Year-to-Date |
Latest WST News | Press Releases
No recent news for West Pharmaceutical Services Inc.
Today’s Trading
| Previous close | 155.68 |
| Today’s open | 154.66 |
| Day’s range | 149.86 - 156.14 |
| Volume | 604,624 |
| Average volume (3 months) | 500,493 |
| Market cap | $11.5B |
Data as of 3:59pm ET, 04/03/2020
Growth & Valuation
| Earnings growth (last year) | +16.66% |
| Earnings growth (this year) | +5.25% |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | +7.31% |
| P/E ratio | 47.1 |
| Price/Sales | 6.15 |
| Price/Book | 7.33 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PODDInsulet Corp | -2.11 | -1.26% |
| TFXTeleflex Inc | -1.26 | -0.43% |
| ABMDABIOMED Inc | -1.63 | -1.14% |
| PENPenumbra Inc | -3.67 | -2.27% |
Data as of 4:00pm ET, 04/03/2020
Financials
| Next reporting date | April 23, 2020 |
| EPS forecast (this quarter) | $0.83 |
| Annual revenue (last year) | $1.8B |
| Annual profit (last year) | $241.7M |
| Net profit margin | 13.11% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Exton, Pennsylvania |
Forecasts
